News
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
4d
MedPage Today on MSNFDA Scrutiny of Novavax COVID Shot Sparks Uncertainty About Other VaccinesThe unusual move at FDA comes shortly after the agency's longtime vaccine chief was forced out over disagreements with Makary ...
3h
Amazon S3 on MSNCovid-19 vaccine side effects, explainedVaccinations for Covid-19 are now underway in the U.S. Two vaccines – one from Pfizer and BioNTech, one from Moderna — have ...
The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
Because the coronavirus continually mutates, manufacturers follow instructions from FDA to make one change each year to their recipe — which strain to target — just like flu vaccines.
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results